Home Antibody All anti-EML1 antibodies
Also for EML1 (NM_001008707)
|Synthetic peptide contain a sequence corresponding to a region within amino acids 772 and 834 of EML1|
|0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.|
|Purified by antigen-affinity chromatography.
|Homo sapiens echinoderm microtubule associated protein like 1 (EML1), transcript variant 1|
|ELP79; EMAP; EMAPL; HuEMAP|
|Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type. The disease process in USHs involves the entire brain and is not limited to the posterior fossa or auditory and visual systems. The USHs are catagorized as type I (USH1A, USH1B, USH1C, USH1D, USH1E and USH1F), type II (USH2A and USH2B) and type III (USH3). The type I is the most severe form. Gene loci responsible for these three types are all mapped. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
A: H1299 ( EML1 antibody anti-EML1 antibody diluted at 1:500)
Sample (30 ug of whole cell lysate) A:NIH-3T3 ( anti-EML1 antibody diluted at 1:1000)